Private: Lawrence Friedhoff, MD, PhD

Dr. Lawrence Friedhoff was responsible for the development and launch of Aricept® the market leading Alzheimer’s disease drug. Dr. Friedhoff is the President and Founder of the Pharmaceutical Special Projects Group (PSPG), a pharmaceutical and biotechnology consulting firm. Prior to founding PSPG Dr. Friedhoff held positions as the Executive Vice President, R&D at Andrx Pharmaceuticals prior to its acquisition by Watson Laboratories. Prior to Andrx, Dr. Friedhoff had been the Executive Vice President of R&D at Eisai USA and Clinical Pharmacology Director at Bristol-Myers Squibb. Dr. Friedhoff has overseen the development and approval of six New Drug Applications including two blockbusters, Aricept(R) and Aciphex(R).